Wire Stories
Bio-Thera Solutions Submits Marketing Authorization Application (MAA) for BAT1706, a Proposed Biosimilar to Avastin�, to European Medicines Agency (EMA)
GUANGZHOU, China–(BUSINESS WIRE)–#biosimilar–Bio-Thera Solutions (SHA: 688177), a commercial-stage biopharmaceutical company, today announced that it has submitted the MAA for BAT1706, a proposed...